======= GATAD2A ======= == Gene Information == * **Official Symbol**: GATAD2A * **Official Name**: GATA zinc finger domain containing 2A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54815|54815]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86YP4|Q86YP4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GATAD2A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GATAD2A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614997|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcriptional repressor. Enhances MBD2-mediated repression. Efficient repression requires the presence of GATAD2B. {ECO:0000269|PubMed:12183469, ECO:0000269|PubMed:16415179}. No Pfam Domain information is available for this gene. |NuRD complex| |DNA alkylation| |DNA methylation| |DNA methylation or demethylation| |protein binding, bridging| |DNA modification| |macromolecule methylation| |methylation| |nuclear speck| |sequence-specific DNA binding| |DNA metabolic process| |zinc ion binding| |negative regulation of transcription by RNA polymerase II| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.47| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-2.21| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|-2.15| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|-2.06| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.93| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-1.87| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.84| |[[:results:exp90|WYE-354 6μM R02 exp90]]|-1.74| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|-1.73| |[[:results:exp436|Dynasore 7μM R08 exp436]]|1.81| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|1.94| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|1.96| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|2.79| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|3.14| ^Gene^Correlation^ |[[:human genes:m:mta2|MTA2]]|0.476| |[[:human genes:m:mbd3|MBD3]]|0.431| Global Fraction of Cell Lines Where Essential: 6/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|1/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5459 * **Expression level (log2 read counts)**: 7.17 {{:chemogenomics:nalm6 dist.png?nolink |}}